The fast pace of innovation in IT offers compelling investment opportunities
Truffle Capital is a pioneer investor in the exciting field of Energy
Biotechnology has radically transformed medicine over the past 25 years
MyoPowers Medical Technologies SA was founded by Dr Piergiorgio Tozzi, MD, of the University Hospital of Lausanne (CHUV), Switzerland and Professor Daniel Hayoz of the Cantonal Hospital of Fribourg and the CHUV. Capitalizing on their long experience in surgery, vascular medicine, and innovative device development, they have developed a unique artificial muscle technology.
MyoPowers’ initial focus is on the application of this proprietary technology in the development of artificial muscles for the treatment of severe incontinences. Myopowers thus has the potential to solve a major medical problem affecting the well being of millions of patients.
Truffle Capital invested in MyoPowers in July 2011.
Truffle Capital board member: Dr. Philippe Pouletty